FBIO — Fortress Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Fortress Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	233	306	178	80.9	57.3
Net Total Accounts Receivable
Net Total Receivables	24.7	23.8	28.3	15.4	10.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	266	346	230	117	90.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32.4	34.1	33	23.5	17.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	333	397	294	168	144
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	51.8	101	128	84.9	71.4
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	233	288	253	145	121
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	100	109	41.7	22.5	22.7
Total Liabilities & Shareholders' Equity	333	397	294	168	144
Total Common Shares Outstanding
Total Preferred Shares Outstanding